MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a neurodegenerative disease defined by the presence of two neuropathological brain lesions: intraneuronal aggregates of tau proteins and extracellular deposition of toxic Aβ peptides, respectively, referred to as tau and amyloid pathologies.